Karyopharm Therapeutics Inc.
KPTI
$8.38
-$0.17-1.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.36% | -65.64% | -66.02% | -52.93% | -43.21% |
| Total Receivables | -14.91% | 0.31% | -14.67% | 13.39% | 10.03% |
| Inventory | -14.79% | -15.11% | 43.61% | 72.23% | 55.73% |
| Prepaid Expenses | -24.98% | -45.57% | -42.37% | -33.55% | 13.24% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -34.08% | -51.42% | -53.07% | -39.39% | -33.11% |
|
|
|||||
| Total Current Assets | -34.08% | -51.42% | -53.07% | -39.39% | -33.11% |
| Net Property, Plant & Equipment | -25.97% | 55.86% | 40.17% | 30.20% | 28.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -63.04% | 2.68% | 2.81% | 2.20% | 2.26% |
| Total Assets | -34.06% | -49.21% | -50.99% | -37.54% | -31.62% |
|
|
|||||
| Total Accounts Payable | -21.62% | -6.76% | -7.15% | 16.79% | 63.53% |
| Total Accrued Expenses | 6.34% | 32.38% | 26.34% | 4.23% | -1.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4,918.04% | 265.92% | 115.32% | -72.93% | -86.76% |
| Total Finance Division Other Current Liabilities | -3.72% | -8.88% | 7.15% | -4.76% | -0.79% |
| Total Other Current Liabilities | -3.72% | -8.88% | 7.15% | -4.76% | -0.79% |
| Total Current Liabilities | -0.22% | 41.73% | 72.19% | 38.31% | 32.79% |
|
|
|||||
| Total Current Liabilities | -0.22% | 41.73% | 72.19% | 38.31% | 32.79% |
| Long-Term Debt | 17.67% | -5.24% | -14.69% | -24.79% | -22.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.44% | -- | 554.55% | 244.21% | 140.66% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 68.64% | -6.19% | -45.06% | 225.68% | 1,434.97% |
| Total Liabilities | 14.53% | 4.69% | -0.67% | -10.66% | -6.96% |
|
|
|||||
| Common Stock & APIC | 6.44% | 1.10% | 1.20% | 1.87% | 1.98% |
| Retained Earnings | -12.54% | -8.13% | -8.23% | -4.10% | -5.14% |
| Treasury Stock & Other | 119.94% | -16.67% | 58.51% | 38.03% | -121.12% |
| Total Common Equity | -57.47% | -68.66% | -80.81% | -21.86% | -36.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -57.47% | -68.66% | -80.81% | -21.86% | -36.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -57.47% | -68.66% | -80.81% | -21.86% | -36.57% |
|
|
|||||